Log in

CVS Group Share Forecast, Price & News

GBX 1,241
+6.00 (+0.49 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: GBX 1,241
50-Day Range
MA: GBX 1,180.54
52-Week Range
Now: GBX 1,241
Volume203,757 shs
Average Volume162,506 shs
Market Capitalization£876.83 million
P/E Ratio71.32
Dividend Yield0.53%
CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services. In addition, it operates MiVetClub, which facilitates the veterinary business management; Animed Direct, an online pharmacy and retailer that sells prescription and non-prescription medicines, premium pet foods, and other animal-related products; and an online dispensary. Further, the company provides burial grounds; and veterinary instrumentation supply and referral services. It owns 491 surgeries in the United Kingdom; 22 sites in the Netherlands; and 3 in the Republic of Ireland, as well as 4 laboratories and 7 crematoria. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.
Read More
CVS Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.95 out of 5 stars

Industry, Sector and Symbol

Industry Personal Services



Sales & Book Value

Annual Sales£435.90 million
Cash FlowGBX 9.85 per share
Book ValueGBX 233.80 per share



Market Cap£876.83 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 1,241
+6.00 (+0.49 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVSG News and Ratings via Email

Sign-up to receive the latest news and ratings for CVSG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CVS Group (LON:CVSG) Frequently Asked Questions

How has CVS Group's stock been impacted by Coronavirus?

CVS Group's stock was trading at GBX 986 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CVSG stock has increased by 25.9% and is now trading at GBX 1,241.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of CVS Group?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Group in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CVS Group

How were CVS Group's earnings last quarter?

CVS Group Plc (LON:CVSG) issued its quarterly earnings results on Friday, September, 29th. The company reported $42.80 earnings per share for the quarter, beating the Zacks' consensus estimate of $42.30 by $0.50. The firm earned $271.80 million during the quarter.
View CVS Group's earnings history

How often does CVS Group pay dividends? What is the dividend yield for CVS Group?

CVS Group declared a dividend on Friday, September 27th. Stockholders of record on Thursday, November 21st will be given a dividend of GBX 5.50 per share on Friday, December 6th. This represents a dividend yield of 0.56%. The ex-dividend date is Thursday, November 21st. This is an increase from CVS Group's previous dividend of GBX 5. The official announcement can be viewed at this link.
View CVS Group's dividend history

What price target have analysts set for CVSG?

5 analysts have issued 1 year target prices for CVS Group's shares. Their forecasts range from GBX 1,050 to GBX 1,400. On average, they expect CVS Group's share price to reach GBX 1,204.80 in the next twelve months. This suggests that the stock has a possible downside of 2.9%.
View analysts' price targets for CVS Group

Who are some of CVS Group's key competitors?

What other stocks do shareholders of CVS Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Group investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), CVS Health (CVS), Burford Capital (BUR), Diageo (DEO), Walt Disney (DIS), Intel (INTC), Marvell Technology Group (MRVL), Micron Technology (MU) and NVIDIA (NVDA).

Who are CVS Group's key executives?

CVS Group's management team includes the following people:
  • Mr. Simon Campbell Innes, Chief Exec. & Exec. Director (Age 59)
  • Mr. Richard William Mark Fairman, Group Fin. Director & Director (Age 51)
  • Mr. Gordon Palmer, Head of IT
  • Mr. Zak Leavold, Commercial Director
  • Prof. John Innes, Referral Director

What is CVS Group's stock symbol?

CVS Group trades on the London Stock Exchange (LON) under the ticker symbol "CVSG."

How do I buy shares of CVS Group?

Shares of CVSG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is CVS Group's stock price today?

One share of CVSG stock can currently be purchased for approximately GBX 1,241.

How big of a company is CVS Group?

CVS Group has a market capitalization of £876.83 million and generates £435.90 million in revenue each year. CVS Group employs 6,150 workers across the globe.

What is CVS Group's official website?

The official website for CVS Group is www.cvsukltd.co.uk.

How can I contact CVS Group?

CVS Group's mailing address is C V S House, Owen Road, DISS, IP22 4ER, United Kingdom. The company can be reached via phone at +44-1379-644288.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.